IL143575A0 - Soluble compositions of triphenylethylene antiestrogens - Google Patents

Soluble compositions of triphenylethylene antiestrogens

Info

Publication number
IL143575A0
IL143575A0 IL14357599A IL14357599A IL143575A0 IL 143575 A0 IL143575 A0 IL 143575A0 IL 14357599 A IL14357599 A IL 14357599A IL 14357599 A IL14357599 A IL 14357599A IL 143575 A0 IL143575 A0 IL 143575A0
Authority
IL
Israel
Prior art keywords
triphenylethylene
corresponding anion
antiestrogens
soluble compositions
triphenylethylene antiestrogens
Prior art date
Application number
IL14357599A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL143575A0 publication Critical patent/IL143575A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IL14357599A 1998-12-17 1999-12-16 Soluble compositions of triphenylethylene antiestrogens IL143575A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI982733A FI982733A (fi) 1998-12-17 1998-12-17 Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
PCT/FI1999/001046 WO2000035485A1 (en) 1998-12-17 1999-12-16 Soluble compositions of triphenylethylene antiestrogens

Publications (1)

Publication Number Publication Date
IL143575A0 true IL143575A0 (en) 2002-04-21

Family

ID=8553138

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14357599A IL143575A0 (en) 1998-12-17 1999-12-16 Soluble compositions of triphenylethylene antiestrogens
IL143575A IL143575A (en) 1998-12-17 2001-06-05 Soluble compositions of triphenylethylene antiestrogens

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143575A IL143575A (en) 1998-12-17 2001-06-05 Soluble compositions of triphenylethylene antiestrogens

Country Status (13)

Country Link
US (2) US6632841B1 (xx)
EP (1) EP1140196B1 (xx)
JP (1) JP4523167B2 (xx)
AT (1) ATE340591T1 (xx)
AU (1) AU767714B2 (xx)
CA (1) CA2355175C (xx)
DE (1) DE69933388T2 (xx)
ES (1) ES2272092T3 (xx)
FI (1) FI982733A (xx)
IL (2) IL143575A0 (xx)
NO (1) NO330251B1 (xx)
NZ (1) NZ512270A (xx)
WO (1) WO2000035485A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US7964734B2 (en) 2002-09-30 2011-06-21 A/S Gea Farmaceutisk Fabrik Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
ES2624557T3 (es) * 2008-12-11 2017-07-14 Besins Healthcare Luxembourg Sarl Composiciones farmacéuticas transdérmicas que comprenden un SERM
PT2895156T (pt) * 2012-09-17 2019-06-28 Pfizer Processo para a preparação de nanopartículas terapêuticas
HUE034490T2 (en) 2013-09-16 2018-02-28 Astrazeneca Ab Therapeutic polymer nanoparticles and methods for their preparation and use
EP3015453B1 (en) * 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of Clomiphene
US10364212B2 (en) 2016-04-22 2019-07-30 F.I.S.—Fabbrica Italiana Sintetici S.p.A. Process for the preparation of enclomiphene citrate having needle shaped crystal habit

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (xx)
FR2558373B1 (fr) 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DE4013696A1 (de) 1989-05-05 1990-11-08 Asta Pharma Ag Salze des azelastins mit verbesserter loeslichkeit
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
GB9126209D0 (en) 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4407742C1 (de) 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5441986A (en) 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases
KR20000035941A (ko) 1996-08-28 2000-06-26 피터 지. 스트링거 무정형 벤조티오펜, 그의 제조 방법 및 용도
CA2219070C (en) * 1996-10-30 2007-12-18 Eli Lilly And Company Methods of preventing breast cancer
US6114395A (en) 1996-11-15 2000-09-05 Pfizer Inc. Method of treating atherosclerosis
DE69804169T2 (de) 1997-06-27 2002-08-29 Akzo Nobel Nv Oral anzuwendende flüssige Arzneilösung
WO1999024032A1 (en) * 1997-11-10 1999-05-20 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) * 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia

Also Published As

Publication number Publication date
NO330251B1 (no) 2011-03-14
CA2355175A1 (en) 2000-06-22
AU767714B2 (en) 2003-11-20
ATE340591T1 (de) 2006-10-15
NO20012793L (no) 2001-08-09
US20030181530A1 (en) 2003-09-25
JP2002532437A (ja) 2002-10-02
NO20012793D0 (no) 2001-06-06
WO2000035485A1 (en) 2000-06-22
US6632841B1 (en) 2003-10-14
ES2272092T3 (es) 2007-04-16
JP4523167B2 (ja) 2010-08-11
DE69933388D1 (de) 2006-11-09
FI982733A (fi) 2000-06-18
DE69933388T2 (de) 2007-08-23
NZ512270A (en) 2003-01-31
CA2355175C (en) 2008-07-15
EP1140196B1 (en) 2006-09-27
US6887888B2 (en) 2005-05-03
EP1140196A1 (en) 2001-10-10
AU1985500A (en) 2000-07-03
IL143575A (en) 2006-12-10
FI982733A0 (fi) 1998-12-17

Similar Documents

Publication Publication Date Title
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
CY1112527T1 (el) Συνθεσεις που περιεχουν αμιοdαrονε και sulfoalkyl ether cyclodextrin
IL143575A0 (en) Soluble compositions of triphenylethylene antiestrogens
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
BG104631A (en) Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
UY25702A1 (es) Desnaturalizantes para las sales aminas simpaticomiméticas
WO2003105767A8 (en) ANTIFUNGAL PARENTERAL PRODUCTS
AR116373A1 (es) Composición para el cuidado de telas
AR034370A1 (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
ES2059899T3 (es) Composicion farmaceutica hidrosoluble de complejos de metallocen.
BR0215303A (pt) Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
CO5560531A2 (es) Producto antitranspirante con dibencilideno sorbitol y elastomero en dimeticona
EP1219296A4 (en) SEBUM PRODUCTION INHIBITORS
ITBO990692A0 (it) Gamba stabilizzatrice per veicoli da lavoro .
ATE250076T1 (de) 6-o-carbamat ketolide derivate
DK1140197T3 (da) Opløselige præparater med toremifen
ES514767A0 (es) Procedimiento para preparar derivados de aminoglicosidos.
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
IL150265A (en) Pharmaceutical compounds including ritanavir and an organic solvent containing long-chain fatty acid and propylene glycol
SE9902742D0 (sv) New pharmaceutical formultion
AR022647A1 (es) Proceso para preparar una formulacion de liberacion sostenida
ITMI20001960A0 (it) Dispositivo di bloccaggio, particolarmente per trattenere in posizione un telaio supporta frutto da applicare ad un corpo scatolare.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed